These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 28658515)

  • 21. Zuclopenthixol dihydrochloride for schizophrenia.
    Bryan EJ; Purcell MA; Kumar A
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD005474. PubMed ID: 29144549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benzodiazepines for schizophrenia.
    Volz A; Khorsand V; Gillies D; Leucht S
    Cochrane Database Syst Rev; 2007 Jan; (1):CD006391. PubMed ID: 17253592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Valproate for schizophrenia.
    Wang Y; Xia J; Helfer B; Li C; Leucht S
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD004028. PubMed ID: 27884042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia.
    Tardy M; Huhn M; Kissling W; Engel RR; Leucht S
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD009268. PubMed ID: 25007358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbamazepine for schizophrenia.
    Leucht S; Helfer B; Dold M; Kissling W; McGrath J
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD001258. PubMed ID: 24789267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabis and schizophrenia.
    McLoughlin BC; Pushpa-Rajah JA; Gillies D; Rathbone J; Variend H; Kalakouti E; Kyprianou K
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004837. PubMed ID: 25314586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluphenazine decanoate (depot) and enanthate for schizophrenia.
    Maayan N; Quraishi SN; David A; Jayaswal A; Eisenbruch M; Rathbone J; Asher R; Adams CE
    Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD000307. PubMed ID: 25654768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chlorpromazine versus atypical antipsychotic drugs for schizophrenia.
    Saha KB; Bo L; Zhao S; Xia J; Sampson S; Zaman RU
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD010631. PubMed ID: 27045703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chlorpromazine versus clotiapine for schizophrenia.
    Mazhari S; Esmailian S; Shah-Esmaeili A; Goughari AS; Bazrafshan A; Zare M
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011810. PubMed ID: 28387925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clozapine dose for schizophrenia.
    Subramanian S; Völlm BA; Huband N
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD009555. PubMed ID: 28613395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mirtazapine adjunct for people with schizophrenia.
    Perry LA; Ramson D; Stricklin S
    Cochrane Database Syst Rev; 2018 May; 5(5):CD011943. PubMed ID: 29802811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chlorpromazine versus penfluridol for schizophrenia.
    Nikvarz N; Vahedian M; Khalili N
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011831. PubMed ID: 28940256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risperidone versus placebo for schizophrenia.
    Rattehalli RD; Zhao S; Li BG; Jayaram MB; Xia J; Sampson S
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD006918. PubMed ID: 27977041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological interventions for treatment-resistant depression in adults.
    Davies P; Ijaz S; Williams CJ; Kessler D; Lewis G; Wiles N
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD010557. PubMed ID: 31846068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluphenazine (oral) versus placebo for schizophrenia.
    Matar HE; Almerie MQ; Sampson SJ
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006352. PubMed ID: 29893410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia.
    Tardy M; Huhn M; Engel RR; Leucht S
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD009369. PubMed ID: 25290157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antipsychotics for schizophrenia spectrum disorders with catatonic symptoms.
    Huang MW; Gibson RC; Jayaram MB; Caroff SN
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013100. PubMed ID: 35844143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive behavioural therapy plus standard care versus standard care for people with schizophrenia.
    Jones C; Hacker D; Xia J; Meaden A; Irving CB; Zhao S; Chen J; Shi C
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD007964. PubMed ID: 30572373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quetiapine versus typical antipsychotic medications for schizophrenia.
    Suttajit S; Srisurapanont M; Xia J; Suttajit S; Maneeton B; Maneeton N
    Cochrane Database Syst Rev; 2013 May; (5):CD007815. PubMed ID: 23728667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.